

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.00212159 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.20756337 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.66121109 |
| 4 | myofibril assembly (GO:0030239) | 7.65414604 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.50229928 |
| 6 | actin-myosin filament sliding (GO:0033275) | 7.37500466 |
| 7 | muscle filament sliding (GO:0030049) | 7.37500466 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 7.16174736 |
| 9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.96474045 |
| 10 | tricarboxylic acid cycle (GO:0006099) | 6.82159298 |
| 11 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.80912928 |
| 12 | regulation of skeletal muscle contraction (GO:0014819) | 6.69586051 |
| 13 | regulation of relaxation of muscle (GO:1901077) | 6.67746195 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.67678398 |
| 15 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.40405970 |
| 16 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.28973410 |
| 17 | regulation of actin filament-based movement (GO:1903115) | 6.24313971 |
| 18 | cardiac muscle cell development (GO:0055013) | 6.14948220 |
| 19 | actin-mediated cell contraction (GO:0070252) | 6.12425714 |
| 20 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.12034757 |
| 21 | regulation of cell communication by electrical coupling (GO:0010649) | 5.90055626 |
| 22 | plasma membrane repair (GO:0001778) | 5.77925647 |
| 23 | cardiac cell development (GO:0055006) | 5.75334402 |
| 24 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.70410829 |
| 25 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.62921356 |
| 26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.61042505 |
| 27 | actomyosin structure organization (GO:0031032) | 5.57655026 |
| 28 | striated muscle contraction (GO:0006941) | 5.56883324 |
| 29 | cardiac muscle hypertrophy (GO:0003300) | 5.50663465 |
| 30 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.45853858 |
| 31 | regulation of sarcomere organization (GO:0060297) | 5.37613877 |
| 32 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.37006941 |
| 33 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.34277677 |
| 34 | carnitine shuttle (GO:0006853) | 5.33179724 |
| 35 | heart process (GO:0003015) | 5.32927446 |
| 36 | heart contraction (GO:0060047) | 5.32927446 |
| 37 | striated muscle hypertrophy (GO:0014897) | 5.25166447 |
| 38 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.20907600 |
| 39 | regulation of cofactor metabolic process (GO:0051193) | 5.19282418 |
| 40 | regulation of coenzyme metabolic process (GO:0051196) | 5.19282418 |
| 41 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.09908660 |
| 42 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.06300241 |
| 43 | adult heart development (GO:0007512) | 5.06298882 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 4.92262771 |
| 45 | oxidative phosphorylation (GO:0006119) | 4.90965824 |
| 46 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.85552291 |
| 47 | respiratory electron transport chain (GO:0022904) | 4.81876837 |
| 48 | muscle tissue morphogenesis (GO:0060415) | 4.80874795 |
| 49 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.67449180 |
| 50 | ATP synthesis coupled proton transport (GO:0015986) | 4.67449180 |
| 51 | electron transport chain (GO:0022900) | 4.66763464 |
| 52 | regulation of membrane repolarization (GO:0060306) | 4.64233976 |
| 53 | muscle hypertrophy (GO:0014896) | 4.64170147 |
| 54 | fatty acid transmembrane transport (GO:1902001) | 4.55636483 |
| 55 | heart trabecula formation (GO:0060347) | 4.53024521 |
| 56 | skeletal muscle contraction (GO:0003009) | 4.49777639 |
| 57 | actin filament-based movement (GO:0030048) | 4.44084066 |
| 58 | skeletal muscle fiber development (GO:0048741) | 4.43584133 |
| 59 | myotube cell development (GO:0014904) | 4.35312079 |
| 60 | cell communication involved in cardiac conduction (GO:0086065) | 4.33482138 |
| 61 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.32266314 |
| 62 | muscle fiber development (GO:0048747) | 4.31345434 |
| 63 | creatine metabolic process (GO:0006600) | 4.25336547 |
| 64 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.21919672 |
| 65 | regulation of the force of heart contraction (GO:0002026) | 4.21765661 |
| 66 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.17239256 |
| 67 | regulation of sulfur metabolic process (GO:0042762) | 4.14611632 |
| 68 | regulation of cardiac muscle contraction (GO:0055117) | 4.11148147 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.09866583 |
| 70 | cardiac muscle cell action potential (GO:0086001) | 4.04273372 |
| 71 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.98674720 |
| 72 | glycogen catabolic process (GO:0005980) | 3.95346189 |
| 73 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.94481803 |
| 74 | NADH metabolic process (GO:0006734) | 3.89760564 |
| 75 | relaxation of cardiac muscle (GO:0055119) | 3.85364860 |
| 76 | carnitine transmembrane transport (GO:1902603) | 3.83570006 |
| 77 | regulation of sequestering of triglyceride (GO:0010889) | 3.83406377 |
| 78 | ubiquinone biosynthetic process (GO:0006744) | 3.82570146 |
| 79 | quinone biosynthetic process (GO:1901663) | 3.82570146 |
| 80 | muscle contraction (GO:0006936) | 3.81605260 |
| 81 | skeletal muscle adaptation (GO:0043501) | 3.79510983 |
| 82 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.78554706 |
| 83 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.78554706 |
| 84 | response to inactivity (GO:0014854) | 3.78264301 |
| 85 | cardiac muscle adaptation (GO:0014887) | 3.78199367 |
| 86 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.78199367 |
| 87 | muscle hypertrophy in response to stress (GO:0003299) | 3.78199367 |
| 88 | regulation of heart rate (GO:0002027) | 3.78040816 |
| 89 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71021100 |
| 90 | regulation of ATPase activity (GO:0043462) | 3.68689995 |
| 91 | regulation of ATP catabolic process (GO:1903289) | 3.68689995 |
| 92 | striated muscle cell development (GO:0055002) | 3.67017965 |
| 93 | glucan catabolic process (GO:0009251) | 3.66032295 |
| 94 | negative regulation of potassium ion transport (GO:0043267) | 3.65849212 |
| 95 | skeletal muscle tissue development (GO:0007519) | 3.64378568 |
| 96 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.62044083 |
| 97 | glycogen biosynthetic process (GO:0005978) | 3.61705634 |
| 98 | glucan biosynthetic process (GO:0009250) | 3.61705634 |
| 99 | striated muscle adaptation (GO:0014888) | 3.61131127 |
| 100 | cell communication by electrical coupling (GO:0010644) | 3.56957276 |
| 101 | positive regulation of cation channel activity (GO:2001259) | 3.56184979 |
| 102 | response to caffeine (GO:0031000) | 3.55981638 |
| 103 | muscle system process (GO:0003012) | 3.55613797 |
| 104 | response to muscle activity (GO:0014850) | 3.50758332 |
| 105 | positive regulation of heart rate (GO:0010460) | 3.50616171 |
| 106 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.47870105 |
| 107 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.47870105 |
| 108 | regulation of heart contraction (GO:0008016) | 3.47559537 |
| 109 | cardiac conduction (GO:0061337) | 3.47495107 |
| 110 | detection of calcium ion (GO:0005513) | 3.44182197 |
| 111 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.43569289 |
| 112 | carnitine transport (GO:0015879) | 3.42391583 |
| 113 | amino-acid betaine transport (GO:0015838) | 3.42391583 |
| 114 | negative regulation of protein localization to cell surface (GO:2000009) | 3.41655300 |
| 115 | cellular polysaccharide catabolic process (GO:0044247) | 3.40779362 |
| 116 | striated muscle atrophy (GO:0014891) | 3.39397600 |
| 117 | aspartate family amino acid catabolic process (GO:0009068) | 3.28546416 |
| 118 | skeletal muscle tissue regeneration (GO:0043403) | 3.20889957 |
| 119 | relaxation of muscle (GO:0090075) | 3.20775891 |
| 120 | muscle cell cellular homeostasis (GO:0046716) | 3.20539475 |
| 121 | regulation of muscle system process (GO:0090257) | 3.19427836 |
| 122 | regulation of muscle contraction (GO:0006937) | 3.18940951 |
| 123 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.14082943 |
| 124 | muscle structure development (GO:0061061) | 3.07857971 |
| 125 | polysaccharide catabolic process (GO:0000272) | 3.07098050 |
| 126 | muscle atrophy (GO:0014889) | 3.06929611 |
| 127 | muscle adaptation (GO:0043500) | 3.04839137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.89617504 |
| 2 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.67689115 |
| 3 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.19152816 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.87806636 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.61458264 |
| 6 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.47285373 |
| 7 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.47285373 |
| 8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.83229074 |
| 9 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 3.28665247 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.20414108 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97309817 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.91000161 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.81431363 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.55093019 |
| 15 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.46544786 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.45567898 |
| 17 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.44418079 |
| 18 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.43799643 |
| 19 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.42984451 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.30586422 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27293360 |
| 22 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.24911677 |
| 23 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.23613900 |
| 24 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.20071990 |
| 25 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.15989216 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.13857818 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.09978069 |
| 28 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.06785949 |
| 29 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.00273714 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.88991609 |
| 31 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.80115882 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.75966288 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.67046411 |
| 34 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.66632630 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61896948 |
| 36 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61522917 |
| 37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.59118783 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.53374997 |
| 39 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.52381638 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51122599 |
| 41 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.48898610 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48427981 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47612102 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46464904 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43291352 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42573458 |
| 47 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.39097000 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37805054 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36995649 |
| 50 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.36765517 |
| 51 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35811979 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35054664 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35054664 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.35048537 |
| 55 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.34806297 |
| 56 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.34416781 |
| 57 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.34416781 |
| 58 | TCF4_23295773_ChIP-Seq_U87_Human | 1.34209922 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33773493 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33329228 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32392991 |
| 62 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.32343005 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30840673 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30388366 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30221353 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30196655 |
| 67 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.27466141 |
| 68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.26786435 |
| 69 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.26730207 |
| 70 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26361605 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26164441 |
| 72 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.25509294 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24985270 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24777810 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23163392 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22496184 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22446664 |
| 78 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21220187 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20599431 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19761272 |
| 81 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.19548432 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17603396 |
| 83 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16301945 |
| 84 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15464952 |
| 85 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15271096 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13928610 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13797792 |
| 88 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.13414385 |
| 89 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12357328 |
| 90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.10200292 |
| 91 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.09421965 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09251818 |
| 93 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06183300 |
| 94 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05600149 |
| 95 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.05580734 |
| 96 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04486610 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03350533 |
| 98 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02993483 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02845385 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02845385 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02775518 |
| 102 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.02490170 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02470113 |
| 104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01808054 |
| 105 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01149231 |
| 106 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.01148616 |
| 107 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99834911 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99152780 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96424525 |
| 110 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96208690 |
| 111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96090725 |
| 112 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96005903 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95177010 |
| 114 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94753623 |
| 115 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.94427239 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93865046 |
| 117 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.93861254 |
| 118 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93339854 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 0.93270506 |
| 120 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.93232921 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92742512 |
| 122 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92644435 |
| 123 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.92494505 |
| 124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91154244 |
| 125 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90730103 |
| 126 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89951559 |
| 127 | NFYB_21822215_ChIP-Seq_K562_Human | 0.89672938 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89635041 |
| 129 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88853788 |
| 130 | TBL1_22424771_ChIP-Seq_293T_Human | 0.88602178 |
| 131 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.88434628 |
| 132 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.88180969 |
| 133 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.87860976 |
| 134 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87351603 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87247699 |
| 136 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86413158 |
| 137 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.86263834 |
| 138 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.86217260 |
| 139 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85002334 |
| 140 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.83642826 |
| 141 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.81362376 |
| 142 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79806350 |
| 143 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.78839646 |
| 144 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78280874 |
| 145 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.78035155 |
| 146 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.77264476 |
| 147 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77124199 |
| 148 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.75944965 |
| 149 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.74701788 |
| 150 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.74143835 |
| 151 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.74052418 |
| 152 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73412301 |
| 153 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72875323 |
| 154 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.71868209 |
| 155 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.71561226 |
| 156 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.70930717 |
| 157 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.69660523 |
| 158 | ATF3_27146783_Chip-Seq_COLON_Human | 0.69058504 |
| 159 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.68634060 |
| 160 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.68606963 |
| 161 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.67050985 |
| 162 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.66063987 |
| 163 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.65825071 |
| 164 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.65800437 |
| 165 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.65508688 |
| 166 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.65450028 |
| 167 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.65274714 |
| 168 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.65250816 |
| 169 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.64806470 |
| 170 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.64758743 |
| 171 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64305066 |
| 172 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.64073184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.46565700 |
| 2 | MP0003646_muscle_fatigue | 6.37244117 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.32465415 |
| 4 | MP0000751_myopathy | 5.25319883 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.73670166 |
| 6 | MP0000749_muscle_degeneration | 4.27775124 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.10318298 |
| 8 | MP0005330_cardiomyopathy | 3.88474101 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.15443219 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 3.07547275 |
| 11 | MP0002972_abnormal_cardiac_muscle | 2.99802812 |
| 12 | MP0000750_abnormal_muscle_regeneration | 2.94835081 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.88166779 |
| 14 | MP0008775_abnormal_heart_ventricle | 2.84186302 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.82938623 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.76893533 |
| 17 | MP0004484_altered_response_of | 2.74349375 |
| 18 | MP0004130_abnormal_muscle_cell | 2.73719505 |
| 19 | MP0002269_muscular_atrophy | 2.56865055 |
| 20 | MP0001544_abnormal_cardiovascular_syste | 2.56433199 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.56433199 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.50133541 |
| 23 | MP0005369_muscle_phenotype | 2.30288733 |
| 24 | MP0000747_muscle_weakness | 2.21982171 |
| 25 | MP0000759_abnormal_skeletal_muscle | 2.21114285 |
| 26 | MP0006138_congestive_heart_failure | 2.13865796 |
| 27 | MP0003828_pulmonary_edema | 2.12153831 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 2.10114693 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 2.03548661 |
| 30 | MP0004085_abnormal_heartbeat | 1.97368905 |
| 31 | MP0002127_abnormal_cardiovascular_syste | 1.83543827 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.77777503 |
| 33 | MP0004233_abnormal_muscle_weight | 1.77417027 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.73962524 |
| 35 | MP0004510_myositis | 1.66286585 |
| 36 | MP0005670_abnormal_white_adipose | 1.55569885 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.51233567 |
| 38 | MP0003567_abnormal_fetal_cardiomyocyte | 1.35005144 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.32601277 |
| 40 | MP0000343_altered_response_to | 1.23889711 |
| 41 | MP0004270_analgesia | 1.15523118 |
| 42 | MP0001661_extended_life_span | 1.14499097 |
| 43 | MP0005165_increased_susceptibility_to | 1.12496022 |
| 44 | MP0000266_abnormal_heart_morphology | 1.12240390 |
| 45 | MP0005266_abnormal_metabolism | 1.09251034 |
| 46 | MP0000372_irregular_coat_pigmentation | 1.04930129 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.02651030 |
| 48 | MP0002108_abnormal_muscle_morphology | 1.01888895 |
| 49 | MP0002234_abnormal_pharynx_morphology | 0.96822732 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 0.96203706 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 0.93997007 |
| 52 | MP0002638_abnormal_pupillary_reflex | 0.92695551 |
| 53 | MP0005375_adipose_tissue_phenotype | 0.89608446 |
| 54 | MP0001984_abnormal_olfaction | 0.79393232 |
| 55 | MP0004142_abnormal_muscle_tone | 0.79198897 |
| 56 | MP0004043_abnormal_pH_regulation | 0.77252084 |
| 57 | MP0002876_abnormal_thyroid_physiology | 0.75904267 |
| 58 | MP0003279_aneurysm | 0.72559741 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.67456237 |
| 60 | MP0010368_abnormal_lymphatic_system | 0.65213134 |
| 61 | MP0002128_abnormal_blood_circulation | 0.63704224 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 0.61679303 |
| 63 | MP0000733_abnormal_muscle_development | 0.60562731 |
| 64 | MP0006276_abnormal_autonomic_nervous | 0.58613325 |
| 65 | MP0005332_abnormal_amino_acid | 0.58488768 |
| 66 | MP0002272_abnormal_nervous_system | 0.56122617 |
| 67 | MP0005623_abnormal_meninges_morphology | 0.55687297 |
| 68 | MP0004147_increased_porphyrin_level | 0.54790434 |
| 69 | MP0001485_abnormal_pinna_reflex | 0.53520581 |
| 70 | MP0003566_abnormal_cell_adhesion | 0.53357193 |
| 71 | MP0009745_abnormal_behavioral_response | 0.52742396 |
| 72 | MP0003941_abnormal_skin_development | 0.50423159 |
| 73 | MP0004134_abnormal_chest_morphology | 0.49845538 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 0.48618161 |
| 75 | MP0002734_abnormal_mechanical_nocicepti | 0.48289982 |
| 76 | MP0002971_abnormal_brown_adipose | 0.48169500 |
| 77 | MP0008872_abnormal_physiological_respon | 0.47097656 |
| 78 | MP0005253_abnormal_eye_physiology | 0.46362324 |
| 79 | MP0003984_embryonic_growth_retardation | 0.45214453 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.44064742 |
| 81 | MP0001299_abnormal_eye_distance/ | 0.43929774 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.43827980 |
| 83 | MP0005645_abnormal_hypothalamus_physiol | 0.43660652 |
| 84 | MP0008569_lethality_at_weaning | 0.43605087 |
| 85 | MP0006072_abnormal_retinal_apoptosis | 0.43246432 |
| 86 | MP0002088_abnormal_embryonic_growth/wei | 0.43163203 |
| 87 | MP0002067_abnormal_sensory_capabilities | 0.42890484 |
| 88 | MP0009046_muscle_twitch | 0.42306476 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.40636363 |
| 90 | MP0005423_abnormal_somatic_nervous | 0.40541686 |
| 91 | MP0003879_abnormal_hair_cell | 0.40052846 |
| 92 | MP0001486_abnormal_startle_reflex | 0.40028097 |
| 93 | MP0000767_abnormal_smooth_muscle | 0.39701104 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.39004692 |
| 95 | MP0004133_heterotaxia | 0.38073566 |
| 96 | MP0005451_abnormal_body_composition | 0.37958662 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.37457570 |
| 98 | MP0002925_abnormal_cardiovascular_devel | 0.35908354 |
| 99 | MP0002102_abnormal_ear_morphology | 0.34318545 |
| 100 | MP0005187_abnormal_penis_morphology | 0.33903968 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.33734534 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.32567898 |
| 103 | MP0005380_embryogenesis_phenotype | 0.32153893 |
| 104 | MP0001672_abnormal_embryogenesis/_devel | 0.32153893 |
| 105 | MP0001853_heart_inflammation | 0.31878879 |
| 106 | MP0002066_abnormal_motor_capabilities/c | 0.31382692 |
| 107 | MP0002064_seizures | 0.29704927 |
| 108 | MP0005646_abnormal_pituitary_gland | 0.27914385 |
| 109 | MP0005334_abnormal_fat_pad | 0.27174288 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.26555521 |
| 111 | MP0003136_yellow_coat_color | 0.26207888 |
| 112 | MP0001784_abnormal_fluid_regulation | 0.25947662 |
| 113 | MP0005535_abnormal_body_temperature | 0.24887086 |
| 114 | MP0005386_behavior/neurological_phenoty | 0.24702662 |
| 115 | MP0004924_abnormal_behavior | 0.24702662 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.24384035 |
| 117 | MP0001614_abnormal_blood_vessel | 0.23998318 |
| 118 | MP0002877_abnormal_melanocyte_morpholog | 0.22679943 |
| 119 | MP0003948_abnormal_gas_homeostasis | 0.22347865 |
| 120 | MP0009115_abnormal_fat_cell | 0.21482817 |
| 121 | MP0001529_abnormal_vocalization | 0.21371767 |
| 122 | MP0003195_calcinosis | 0.21175137 |
| 123 | MP0002822_catalepsy | 0.20790284 |
| 124 | MP0000358_abnormal_cell_content/ | 0.19618163 |
| 125 | MP0000013_abnormal_adipose_tissue | 0.18620857 |
| 126 | MP0003045_fibrosis | 0.17705466 |
| 127 | MP0000579_abnormal_nail_morphology | 0.17129110 |
| 128 | MP0005452_abnormal_adipose_tissue | 0.17039244 |
| 129 | MP0003186_abnormal_redox_activity | 0.14990090 |
| 130 | MP0000762_abnormal_tongue_morphology | 0.14771033 |
| 131 | MP0005595_abnormal_vascular_smooth | 0.11622022 |
| 132 | MP0001697_abnormal_embryo_size | 0.10198267 |
| 133 | MP0005275_abnormal_skin_tensile | 0.10072841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.35312929 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.79486720 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.67041659 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.30173512 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.29747930 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 6.17801291 |
| 7 | Atrial fibrillation (HP:0005110) | 5.89731004 |
| 8 | Muscle fiber splitting (HP:0003555) | 5.73793636 |
| 9 | Primary atrial arrhythmia (HP:0001692) | 5.50684261 |
| 10 | Supraventricular tachycardia (HP:0004755) | 5.34450318 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 5.29144842 |
| 12 | Myoglobinuria (HP:0002913) | 5.24305357 |
| 13 | Supraventricular arrhythmia (HP:0005115) | 5.20508769 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 5.00330143 |
| 15 | Lipoatrophy (HP:0100578) | 4.93885445 |
| 16 | Distal arthrogryposis (HP:0005684) | 4.76472531 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 4.70526095 |
| 18 | Myopathic facies (HP:0002058) | 4.58549490 |
| 19 | Syncope (HP:0001279) | 4.50485916 |
| 20 | Bundle branch block (HP:0011710) | 4.47648463 |
| 21 | Subaortic stenosis (HP:0001682) | 4.41199176 |
| 22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.41199176 |
| 23 | Dilated cardiomyopathy (HP:0001644) | 4.24614942 |
| 24 | Palpitations (HP:0001962) | 4.24010424 |
| 25 | EMG: myopathic abnormalities (HP:0003458) | 4.22698463 |
| 26 | Rhabdomyolysis (HP:0003201) | 4.18976402 |
| 27 | Increased connective tissue (HP:0009025) | 3.91055249 |
| 28 | Prolonged QT interval (HP:0001657) | 3.82455168 |
| 29 | Round ear (HP:0100830) | 3.77288023 |
| 30 | Heart block (HP:0012722) | 3.73914877 |
| 31 | Muscle fiber inclusion bodies (HP:0100299) | 3.72142163 |
| 32 | Difficulty running (HP:0009046) | 3.70791780 |
| 33 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.63845290 |
| 34 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.63296825 |
| 35 | Ventricular arrhythmia (HP:0004308) | 3.62480624 |
| 36 | Acute necrotizing encephalopathy (HP:0006965) | 3.60653286 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 3.56085639 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.56045754 |
| 39 | Abnormal atrioventricular conduction (HP:0005150) | 3.51479021 |
| 40 | Frequent falls (HP:0002359) | 3.44242869 |
| 41 | Ulnar deviation of the wrist (HP:0003049) | 3.38971883 |
| 42 | Myotonia (HP:0002486) | 3.37747149 |
| 43 | Hepatic necrosis (HP:0002605) | 3.36907762 |
| 44 | Atrioventricular block (HP:0001678) | 3.35743892 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 3.32210823 |
| 46 | Absent phalangeal crease (HP:0006109) | 3.12779256 |
| 47 | Areflexia of lower limbs (HP:0002522) | 3.11870158 |
| 48 | Acute encephalopathy (HP:0006846) | 3.04626709 |
| 49 | Progressive macrocephaly (HP:0004481) | 2.98762426 |
| 50 | Left ventricular hypertrophy (HP:0001712) | 2.98002099 |
| 51 | Hepatocellular necrosis (HP:0001404) | 2.97756875 |
| 52 | Nemaline bodies (HP:0003798) | 2.95723914 |
| 53 | Ventricular fibrillation (HP:0001663) | 2.95112169 |
| 54 | Abnormality of alanine metabolism (HP:0010916) | 2.92598506 |
| 55 | Hyperalaninemia (HP:0003348) | 2.92598506 |
| 56 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.92598506 |
| 57 | Mitochondrial inheritance (HP:0001427) | 2.89471286 |
| 58 | Difficulty climbing stairs (HP:0003551) | 2.86196446 |
| 59 | Calcaneovalgus deformity (HP:0001848) | 2.83326288 |
| 60 | Abnormal EKG (HP:0003115) | 2.80404217 |
| 61 | Increased CSF lactate (HP:0002490) | 2.80129513 |
| 62 | Muscle stiffness (HP:0003552) | 2.75009436 |
| 63 | Cerebral edema (HP:0002181) | 2.68168768 |
| 64 | Testicular atrophy (HP:0000029) | 2.67439848 |
| 65 | Exercise intolerance (HP:0003546) | 2.64701362 |
| 66 | Abnormal finger flexion creases (HP:0006143) | 2.61411264 |
| 67 | Type 1 muscle fiber predominance (HP:0003803) | 2.60976373 |
| 68 | Rimmed vacuoles (HP:0003805) | 2.60773956 |
| 69 | Ketoacidosis (HP:0001993) | 2.57992702 |
| 70 | Deformed tarsal bones (HP:0008119) | 2.56344820 |
| 71 | Hypoglycemic coma (HP:0001325) | 2.55321419 |
| 72 | Increased muscle lipid content (HP:0009058) | 2.54482408 |
| 73 | Palmoplantar keratoderma (HP:0000982) | 2.51852213 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.50205052 |
| 75 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50205052 |
| 76 | Neck muscle weakness (HP:0000467) | 2.46775651 |
| 77 | Lactic acidosis (HP:0003128) | 2.45396873 |
| 78 | Malignant hyperthermia (HP:0002047) | 2.44207225 |
| 79 | Increased variability in muscle fiber diameter (HP:0003557) | 2.36805797 |
| 80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.34897879 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 2.34417012 |
| 82 | Respiratory failure (HP:0002878) | 2.32063961 |
| 83 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.31980941 |
| 84 | Limb-girdle muscle atrophy (HP:0003797) | 2.30169510 |
| 85 | Hyperkalemia (HP:0002153) | 2.28473442 |
| 86 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.22860306 |
| 87 | Distal lower limb amyotrophy (HP:0008944) | 2.18419214 |
| 88 | Scapular winging (HP:0003691) | 2.12085018 |
| 89 | Hypoplastic ischia (HP:0003175) | 2.11701798 |
| 90 | Muscular dystrophy (HP:0003560) | 2.09859388 |
| 91 | Bulbar palsy (HP:0001283) | 2.07950268 |
| 92 | Weak cry (HP:0001612) | 2.07184187 |
| 93 | Proximal amyotrophy (HP:0007126) | 2.06959595 |
| 94 | Slender build (HP:0001533) | 2.06136182 |
| 95 | Fetal akinesia sequence (HP:0001989) | 2.04059728 |
| 96 | Central scotoma (HP:0000603) | 2.00701784 |
| 97 | Fatigable weakness (HP:0003473) | 2.00084406 |
| 98 | Abnormality of the neuromuscular junction (HP:0003398) | 2.00084406 |
| 99 | Progressive muscle weakness (HP:0003323) | 1.98647093 |
| 100 | Lipid accumulation in hepatocytes (HP:0006561) | 1.96005653 |
| 101 | Facial diplegia (HP:0001349) | 1.95769493 |
| 102 | EMG: neuropathic changes (HP:0003445) | 1.95601858 |
| 103 | Gowers sign (HP:0003391) | 1.94084113 |
| 104 | Hip contracture (HP:0003273) | 1.91505662 |
| 105 | Ragged-red muscle fibers (HP:0003200) | 1.91220214 |
| 106 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90590800 |
| 107 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90590800 |
| 108 | Large for gestational age (HP:0001520) | 1.89910417 |
| 109 | Esophageal neoplasm (HP:0100751) | 1.88442583 |
| 110 | Neoplasm of head and neck (HP:0012288) | 1.88442583 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87795464 |
| 112 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.87581482 |
| 113 | Increased serum lactate (HP:0002151) | 1.87075277 |
| 114 | Generalized muscle weakness (HP:0003324) | 1.86419085 |
| 115 | Waddling gait (HP:0002515) | 1.85334891 |
| 116 | Foot dorsiflexor weakness (HP:0009027) | 1.85324886 |
| 117 | Conjunctival hamartoma (HP:0100780) | 1.84666917 |
| 118 | Abnormality of the foot musculature (HP:0001436) | 1.84387647 |
| 119 | Optic disc pallor (HP:0000543) | 1.82359448 |
| 120 | Abnormality of the ischium (HP:0003174) | 1.80720366 |
| 121 | Increased serum pyruvate (HP:0003542) | 1.80186397 |
| 122 | Abnormality of glycolysis (HP:0004366) | 1.80186397 |
| 123 | Congestive heart failure (HP:0001635) | 1.79739912 |
| 124 | Toxemia of pregnancy (HP:0100603) | 1.79392432 |
| 125 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.75419454 |
| 126 | Type 2 muscle fiber atrophy (HP:0003554) | 1.65777783 |
| 127 | Spinal rigidity (HP:0003306) | 1.61566325 |
| 128 | Nonprogressive disorder (HP:0003680) | 1.57231498 |
| 129 | Steppage gait (HP:0003376) | 1.54726380 |
| 130 | Oligomenorrhea (HP:0000876) | 1.53566948 |
| 131 | Long clavicles (HP:0000890) | 1.45122803 |
| 132 | Hyperglycinuria (HP:0003108) | 1.44882445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.38058932 |
| 2 | OBSCN | 5.32577918 |
| 3 | PHKG2 | 4.48342067 |
| 4 | PHKG1 | 4.48342067 |
| 5 | PDK4 | 3.93870374 |
| 6 | PDK3 | 3.93870374 |
| 7 | LMTK2 | 3.23877405 |
| 8 | MYLK | 3.12593693 |
| 9 | PINK1 | 2.85020056 |
| 10 | PDK2 | 2.68276469 |
| 11 | NEK1 | 2.68237766 |
| 12 | DMPK | 2.63953337 |
| 13 | BCKDK | 2.50673229 |
| 14 | MUSK | 2.47089954 |
| 15 | GRK7 | 2.20850814 |
| 16 | ZAK | 2.15579964 |
| 17 | PKN2 | 2.12508697 |
| 18 | PIK3CA | 2.07213236 |
| 19 | FRK | 2.00776358 |
| 20 | TIE1 | 1.78922638 |
| 21 | STK24 | 1.72064732 |
| 22 | MARK1 | 1.59046166 |
| 23 | CAMK2D | 1.24034935 |
| 24 | STK38L | 1.22168137 |
| 25 | BMPR1B | 1.21475883 |
| 26 | TRIB3 | 1.16518286 |
| 27 | STK4 | 1.15061878 |
| 28 | INSRR | 1.05880126 |
| 29 | ERBB3 | 1.04381734 |
| 30 | PRKD1 | 1.03600409 |
| 31 | NME1 | 1.03126320 |
| 32 | PAK3 | 1.02874270 |
| 33 | MAPK12 | 1.00877406 |
| 34 | LIMK1 | 1.00292826 |
| 35 | MAP3K7 | 0.99893710 |
| 36 | ADRBK2 | 0.95899913 |
| 37 | PRKAA1 | 0.94148377 |
| 38 | FLT3 | 0.89760426 |
| 39 | MAP2K3 | 0.86152637 |
| 40 | MAP2K4 | 0.85558790 |
| 41 | MAP4K2 | 0.85031732 |
| 42 | PRKAA2 | 0.83814882 |
| 43 | MAPK13 | 0.82896742 |
| 44 | CAMK4 | 0.82638748 |
| 45 | CDC42BPA | 0.81251828 |
| 46 | TRPM7 | 0.80663680 |
| 47 | PKN1 | 0.80252501 |
| 48 | MAPKAPK3 | 0.80121103 |
| 49 | NME2 | 0.79954591 |
| 50 | ACVR1B | 0.79719925 |
| 51 | WNK3 | 0.77888624 |
| 52 | MAP3K5 | 0.77154645 |
| 53 | ROCK1 | 0.74721032 |
| 54 | DAPK2 | 0.72476590 |
| 55 | ILK | 0.69115414 |
| 56 | NEK9 | 0.62845477 |
| 57 | PIK3CG | 0.61994674 |
| 58 | CAMK2A | 0.58191598 |
| 59 | STK38 | 0.58072697 |
| 60 | TNIK | 0.57114155 |
| 61 | RPS6KC1 | 0.55727049 |
| 62 | RPS6KL1 | 0.55727049 |
| 63 | CCNB1 | 0.54729824 |
| 64 | AKT2 | 0.52806995 |
| 65 | OXSR1 | 0.52544605 |
| 66 | MAP2K1 | 0.52166292 |
| 67 | CAMK2B | 0.51125873 |
| 68 | PRKACB | 0.50665081 |
| 69 | MAP3K3 | 0.49965643 |
| 70 | CAMK2G | 0.45611320 |
| 71 | PRKACA | 0.45165409 |
| 72 | WNK4 | 0.44850315 |
| 73 | TAOK3 | 0.44705762 |
| 74 | RPS6KA6 | 0.44467248 |
| 75 | ROCK2 | 0.42896882 |
| 76 | IRAK3 | 0.41897024 |
| 77 | NUAK1 | 0.41824003 |
| 78 | MAP3K4 | 0.41671072 |
| 79 | MAPK4 | 0.40268847 |
| 80 | NLK | 0.39763189 |
| 81 | CAMK1 | 0.39672936 |
| 82 | DAPK3 | 0.38815562 |
| 83 | TGFBR2 | 0.38362989 |
| 84 | WNK1 | 0.36952940 |
| 85 | PRKACG | 0.34925683 |
| 86 | KDR | 0.34793515 |
| 87 | PRKCE | 0.33550996 |
| 88 | TTK | 0.32128272 |
| 89 | TAOK2 | 0.30073690 |
| 90 | PTK2B | 0.29926212 |
| 91 | RPS6KA1 | 0.29920671 |
| 92 | STK11 | 0.29296696 |
| 93 | MAP2K6 | 0.29237727 |
| 94 | PNCK | 0.27382211 |
| 95 | AKT3 | 0.26591102 |
| 96 | MAPK7 | 0.26017913 |
| 97 | PDGFRA | 0.25687066 |
| 98 | DYRK1B | 0.25390360 |
| 99 | SGK223 | 0.20488699 |
| 100 | SGK494 | 0.20488699 |
| 101 | SGK3 | 0.20145764 |
| 102 | TGFBR1 | 0.20140939 |
| 103 | SGK1 | 0.19760345 |
| 104 | CASK | 0.19662867 |
| 105 | STK39 | 0.19601460 |
| 106 | PRKG1 | 0.19427464 |
| 107 | ICK | 0.18138747 |
| 108 | PLK2 | 0.17467945 |
| 109 | MOS | 0.17054203 |
| 110 | SGK2 | 0.16172133 |
| 111 | RPS6KB1 | 0.14975370 |
| 112 | MARK3 | 0.14568186 |
| 113 | PRKCA | 0.14332785 |
| 114 | PAK6 | 0.14240379 |
| 115 | PRKCQ | 0.13800876 |
| 116 | LATS2 | 0.13546313 |
| 117 | MKNK2 | 0.13341861 |
| 118 | TLK1 | 0.13162298 |
| 119 | ADRBK1 | 0.13102143 |
| 120 | MAPK11 | 0.12378358 |
| 121 | LATS1 | 0.12219518 |
| 122 | RPS6KA3 | 0.12095175 |
| 123 | PDK1 | 0.11801362 |
| 124 | RIPK1 | 0.11703618 |
| 125 | PDPK1 | 0.09327992 |
| 126 | EPHA3 | 0.07570701 |
| 127 | CDK4 | 0.07332329 |
| 128 | CSNK1D | 0.06971753 |
| 129 | MTOR | 0.06224329 |
| 130 | SRPK1 | 0.04704989 |
| 131 | GRK1 | 0.04464537 |
| 132 | RPS6KB2 | 0.03022113 |
| 133 | AURKB | 0.02970418 |
| 134 | MAP3K6 | 0.01336925 |
| 135 | PRKDC | 0.01030145 |
| 136 | AKT1 | 0.00824943 |
| 137 | MAPK8 | 0.00455208 |
| 138 | JAK1 | -0.0140021 |
| 139 | MAPKAPK2 | -0.0060944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.09237518 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.44051418 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.39729857 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.78650667 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.76546846 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.62506145 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.58423420 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.44889285 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.89077337 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.76646638 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.72961872 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.64445318 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.57883531 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.57081625 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.53116791 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43035769 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99911732 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71779702 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58757079 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56163620 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37209787 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37193526 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21198751 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19440242 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17406343 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16738637 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12486676 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07015512 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06342477 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91545156 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90145283 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 0.88286097 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88013988 |
| 34 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87648331 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86323342 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82752279 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80891380 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79631082 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78803583 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76815362 |
| 41 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76558767 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75733923 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71846828 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70455235 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 0.70445281 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67353632 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 0.65521783 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64226204 |
| 49 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60450861 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59203130 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.58455861 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57310669 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55787618 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54597635 |
| 55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54262789 |
| 56 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52482985 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50690214 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.50289751 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50146991 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49041421 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44435997 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.43874521 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43397491 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43375856 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42886612 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.42718385 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41755699 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41211926 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40503399 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39870530 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39661142 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.39412017 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38601248 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38296246 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.38166439 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36889984 |
| 77 | Focal adhesion_Homo sapiens_hsa04510 | 0.35825074 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35636674 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.34964113 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34863838 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34725249 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34331971 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.33024538 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32905040 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.32885346 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.32473761 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32129654 |
| 88 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.30959176 |
| 89 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.30350388 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29651650 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28238357 |
| 92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.28119401 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27158178 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.26899559 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25548988 |
| 96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25472050 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.25234609 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24884451 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.24737551 |
| 100 | Proteasome_Homo sapiens_hsa03050 | 0.24603136 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.23940082 |
| 102 | RNA degradation_Homo sapiens_hsa03018 | 0.18372069 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15505808 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.13709108 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.13246070 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.13080666 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11418906 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10725331 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09535792 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09535190 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.09150519 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.08316540 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.08042146 |
| 114 | Ribosome_Homo sapiens_hsa03010 | 0.07729192 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.05761827 |
| 116 | Mismatch repair_Homo sapiens_hsa03430 | 0.05118958 |
| 117 | Taste transduction_Homo sapiens_hsa04742 | 0.04929857 |
| 118 | Homologous recombination_Homo sapiens_hsa03440 | 0.03263482 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03132741 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.01004612 |
| 121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.00308947 |
| 122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0832057 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0774169 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | -0.0697579 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | -0.0579870 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.0577923 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | -0.0538699 |
| 128 | Fanconi anemia pathway_Homo sapiens_hsa03460 | -0.0234537 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0218156 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0193751 |
| 131 | Circadian entrainment_Homo sapiens_hsa04713 | -0.0167681 |
| 132 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0118376 |

